Areas of Focus
- Selenoproteins and tumorigenesis mechanisms
- Antitumor drugs
Work Experience
- 2012-2019 - Chongqing Medical University - Lecturer
- 2019-present - Chongqing Medical University - Associate Professor
Academic Background & Achievements
- 2002-2006 Bachelor: Huazhong University of Science and Technology
- 2006-2012 Doctorate: Huazhong University of Science and Technology
- Hosted National Natural Science Foundation project
- Published 4 SCI papers in the last five years
Publications
- An integrative pan-cancer bioinformatics analysis of MSRB1 and its association with tumor immune microenvironment, prognosis, and immunotherapy., Jiang S, Yang S, Gao Z, Yin C, Zhang M, Wu Q, Li Y, 2024
- RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis., Li Y, Wang NX, Yin C, Jiang SS, Li JC, Yang SY, 2022
- MsrB1 Promotes Proliferation and Invasion of Colorectal Cancer Cells via GSK-3β/β-catenin Signaling Axis., Chen XY, Yang SY, Ruan XJ, Ding HY, Wang NX, Liu F, Li JC, Li Y, 2021
- 8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway., Ding HY, Yang WY, Zhang LH, Li L, Xie F, Li HY, Chen XY, Tu Z, Li Y, Chen Y, Yang SY, 2020
- Effect of methionine sulfoxide reductase B1 silencing on high-glucose-induced apoptosis of human lens epithelial cells., Li Y, Jia Y, Zhou J, Huang K, 2013
- Effect of streptozocin-induced diabetes mellitus on expression of methionine sulfoxide reductases and accumulation of their substrates in mouse lenses., Li Y, Zhang W, Li P, Huang K, 2011